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Abstract
Background: Hemichorea–hemiballism is a syndrome secondary to different etiologies. Drug-induced hemichorea is a rare syndrome related to selective serotonin
reuptake inhibitors. To the best of our knowledge, no previous cases of hemichorea associated with sertraline have been reported.
Case Report: A 65-year-old female noticed hemichorea 1 week after initiation of sertraline. After extensive investigations, other causes of hemichorea were
excluded. Hemichorea remitted after sertraline withdrawal.
Discussion: In our patient, temporal association and the negative clinical assessment supported a diagnosis of likely drug-induced involuntary movement.
We hypothesized that enhanced serotonergic transmission in the ventral tegmental area or nigrostriatum may be involved in sertraline-induced hemichorea.
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Introduction
Hemichorea–hemiballism is a spectrum of involuntary, non-
patterned movement involving one side of the body. It usually results
from a lesion in the contralateral basal ganglia structure, but it is also a
well-recognized complication of several conditions, including non-ketotic
hyperglycemia and polycythemia vera.1
Although induced parkinsonisms and other hyperkinetic movement
disorders are repeatedly reported with selective serotonin reuptake inhi-
bitors (SSRIs),2,3 drug-induced hemichorea has rarely been reported4–9
(Table 1). Herein we report a case of hemichorea induced by sertraline.
To the best of our knowledge, no previous cases of sertraline-induced
hemichorea have been reported in the literature.
Case report
A 65-year-old right-handed Argentinean female was diagnosed with
depression and was started on sertraline 50 mg per day. One week
later, she developed involuntary movements involving the left upper
and lower limbs.
Twenty-four hours later she was admitted into our institution.
Physical examination revealed hemichorea on the left side, but the rest
of the neurological and clinical examination, including the Mini
Mental Status Examination, was unremarkable.
The patient’s past medical history included smoking (more than
40 cigarettes/day), hiatus hernia, and irritable bowel syndrome. She
had no other significant disorders involving the central, peripheral, or
autonomic nervous systems. Her family history was non-contributory
and no additional medications were taken in the previous 6 months,
even for irritable bowel syndrome.
A 1.5 Tesla brain magnetic resonance imaging scan including
diffusion-weighted images and magnetic resonance angiography (MRA)
was performed 48 hours after the initial symptoms, and no acute lesions
or relevant abnormalities were identified (Figure 1). Routine blood
tests demonstrated no abnormalities in the full blood count (hemoglobin,
13.2 g/dL; hematocrit, 39.20%) and liver or renal function. Thyroid
function, blood glucose, calcium, magnesium, phosphate, serum cerulo-
plasmin, vitamin D, and parathyroid hormone levels were all normal.
Serum carcinoembryonic antigen, cancer antigen (CA) 15.3, CA 19.9,
CA 125, paraneoplastic antibodies (anti-Yo, anti-Hu, anti-Ri), p-Antinuclear
and anticytoplasmic antibodies (ANCA) and c-ANCA, anti-transglutaminase,
anti-gliadin, and anti-endomysium antibodies, anti-nuclear antibody,
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anti-cardiolipin antibody, and HIV serology were negative. To exclude
other systemic causes, chest, abdominal, and pelvic computed tomo-
graphy (CT) scans were performed, which were normal. Carotid
ultrasound, echocardiogram, and upper and lower endoscopy were
normal.
Cerebrospinal fluid analysis was unremarkable, and onconeural
antibodies were negative (anti-Yo, anti-Hu, anti-Ri, anti-N-methyl-D-
aspartic acid receptor, anti-Antiglutamate receptor (AMPA subtype1),
anti-Antiglutamate receptor (AMPA subtype2), anti-Contactin asso-
ciated protein 2 (CASPR2), anti-Leucine rich glioma inactivated 1 (LGI 1),
gamma-aminobutyric acid B-receptor (GABAB-R), collapsin response
mediator protein 5 (CRMP5)). As no other etiologic agents were identi-
fied, sertraline was discontinued and the involuntary movements gradually
disappeared over 7 days.
The patient was diagnosed with a probable sertraline drug-induced
hemichorea. See video, segment 1: basal examination, segment 2: evalua-






















































































































































































































































































































































































































































































































































































































































































































































































































Figure 1. 1.5 Tesla Brain Magnetic Resonance Imaging. (A) T1-
weighted sequences. (B) T2-weighted sequences. (C) Fluid attenuation inversion
recovery (FLAIR)-weighted sequences.
Video 1. Sertraline-induced Hemichorea. Segment 1. Patient at the
initial examination with hemichoreatic movement involving the left hemibody.
Segment 2. Patient 1 month after initial presentation with clinical improvement.
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Discussion
We present a patient with hemichorea related to sertraline therapy.
Sertraline is a SSRI, commonly used in depression.10 According to the
pharmaco-epidemiological data by the US Food and Drug Admini-
stration, only 10% of all SSRI-induced movement disorders have been
reported to be secondary to sertraline,11 particularly in those cases with
concomitant medications.11,12
The most common movement disorders induced by sertraline
included tremor, dystonia, and akathisia.12 However, to the best of our
knowledge, no previous chorea or hemichorea cases associated with
sertraline have been previously reported.
The mechanism by which SSRI could induce movement disorders
remains to be elucidated.13 Two possible mechanisms have been pro-
posed. The first suggested that sertraline is able not only to inhibit
serotonin reuptake but also to exert a mild dopaminergic inhibition in
the ventral tegmental area and nigrostriatal pathway.14 The second
hypothesis proposed a genetic mechanism involving serotonin or
dopamine receptor polymorphisms or cytochrome P450 phenotypes.15
These two hypotheses may explain the usually bilateral acute or tardive
symptoms; however, it remains to be elucidated why hemichorea rather
than generalized chorea occurred in this case.
Several concomitant and previous conditions could contribute to
increase the susceptibility for developing hemichorea. In our patient
we ruled out chorea gravidarum, post-streptococcal chorea, auto-
immune-mediated hemichorea, polycythemia vera, and vascular and
structural causes, among others.1
While in this case a personal history of smoking could be observed as
a risk factor for hemichorea development, in the literature only one
case of smoking was reported as a worsening and non-primary causal
factor in a 65-year-old hypertensive male with a right putamen hemor-
rhage.16 In our patient, smoking did not seem to be involved in the
pathogenesis of the hemichorea. Therefore, the acute appearance of
hemichorea and the recent administration of sertraline, after excluding
other possible causes of acquired hemichorea, suggest a probable drug-
induced mechanism.
Although the extended use of sertraline revealed a safe profile in
daily doses ranging from 50 to 200 mg, it is important to keep in mind
that this drug may induce hemichorea, albeit very rarely.
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